At ESC Congress 2023 we will be 'joining forces to protect the heart' and create the future of cardiology – a future where everything is possible.
Dr Jorg Taubel will be attending in person along with Dr Julian Gilmore from the Royal Free London NHS Foundation Trust who will be presenting ‘ATTRibute-CM: acoramidis (AG10) in patients with transthyretin amyloid cardiomyopathy’
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
